01449nam a2200325 c 4500001001300000005001500013007000300028008004100031049002800072052001800100056001500118082001600133245028500149260006400434300004600498650005300544700006100597700003600658700005600694700005600750700004400806880005500850880006600905880002900971880002601000880002801026880002501054880002701079950001701106KMO20155838320171221150115ta151008s2015    ulkad         000   kor  0 lEM6254895lEM6254896c201a513.042b15-2  a513.0422601a616.042223006880-01a파브리병의 전문가적 의견 :b파브리병 환자의 효소대체치료 시점에 대한 기준 =xkorean fabry expert opinions : Consensus on guidance : when to start enzyme replacement therapy /d저자: 김대성,e김도완,e김수현,e유한욱,e홍그루  6880-02a서울 :bMcCANN Health Communications Korea,c2015  a30 p. :b천연색삽화, 도표 ;c26 cm 8a유전성 질환[遺傳性疾患]0KSH19980057011 6880-03a김대성,g金大成,d1963-0KAC2015207894aut1 6880-04a김도완0KAC2015207901 6880-05a김수현,g金秀賢,d1976-0KAC2015207911 6880-06a유한욱,g柳漢旭,d1954-0KAC2015207921 6880-07a홍그루,d1967-0KAC201418555006245-01/(BaPabeuri byeong ui jeonmungajeok uigyeon  6260-02/(BaSeoul :bMcCANN Health Communications Korea,c20151 6700-03/(BaGim, Daeseong1 6700-04/(BaGim, Dowan1 6700-05/(BaGim, Suhyeon1 6700-06/(BaYu, Hanuk1 6700-07/(BaHong, Geuru1 a가격불명